JLS is an NY-based venture capital fund formed to invest in the exciting intersection of science, technology and neurology, leveraging the enormous potential of plant-based and psychedelic medicines to heal illness and enhance wellness. They focus on the development of drugs for intractable mental and physical conditions and the enabling technology and tools that can accelerate and enhance the delivery of those therapies.
6
Total Investments
5
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Financial Services
Company Overview
About JLS Fund
Recent Investments (6)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Dec 2022 | |
| Seed Round | •••••• | Apr 2022 | |
| Seed Round | •••••• | Nov 2021 | |
| Seed Round | •••••• | Jul 2021 | |
| Series A | •••••• | May 2021 | |
|
|
Post-IPO Equity | •••••• | Mar 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.